Lyso-Monosialoganglioside GM2 (ammonium salt)
(Synonyms: Lysoganglioside GM2, Lyso-GM2, lyso-Monosialoganglioside GM2) 目录号 : GC48345A sphingolipid
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Lyso-monosialoganglioside GM2 (Lyso-GM2) is a form of ganglioside GM2 that is lacking the fatty acyl group. Lyso-GM2 inhibits PKC in a cell-free assay (IC50 = 50 µM).1 Levels of lyso-GM2 are increased in the gray matter of postmortem brain samples from patients with Sandhoff disease or Tay-Sachs disease, as well as in a mouse model of Sandhoff disease.2,3 [Matreya, LLC. Catalog No. 1543]
1.Hannun, Y.A., and Bell, R.M.Lysosphingolipids inhibit protein kinase C: Implications for the sphingolipidosesScience235(4789)670-674(1987) 2.Kobayashi, T., Goto, I., Okada, S., et al.Accumulation of lysosphingolipids in tissues from patients with GM1 and GM2 gangliosidosesJ. Neurochem.59(4)1452-1458(1992) 3.Kodama, T., Togawa, T., Tsukimura, T., et al.Lyso-GM2 ganglioside: A possible biomarker of Tay-Sachs disease and Sandhoff diseasePLoS One6(12)e29074(2011)
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 0.8808 mL | 4.4041 mL | 8.8082 mL |
5 mM | 0.1762 mL | 0.8808 mL | 1.7616 mL |
10 mM | 0.0881 mL | 0.4404 mL | 0.8808 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。